Is AbbVie the Most Underrated Dividend Growth Stock in the S&P 500?
For a solid yield and strong upside potential, this pharmaceutical stock is worth considering.
Is AbbVie the Most Underrated Dividend Growth Stock in the S&P 500?
Overview
When it comes to major dividend growth stocks, many come to mind, particularly widely held consumer staples stocks. However, because of their popularity, many have arguably become stretched in terms of valuation and potential upside.
In contrast, AbbVie (NYSE: ABBV), while one of the well-known dividend stocks among the S&P 500, has yet to become overvalued. It continues to offer investors a fantastic mix of value, growth, and yield.
Image source: Getty Images.
Details
Source
Originally published at www.fool.com.
Related Articles
- 51% of U.S. adults say the American Dream is out of reach for most people right now: CNBC survey
- A massive 16% market swing just rocked South Korea over 24 hours. The retail ‘ants’ holding the wheel are driving dangerously.
- I’m 60, retired with $3 million. My fiancée, 55, has $1 million but plans to work for the next 10 years. Are we compatible?
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.
